CRBP - CIK 0001595097
The table below shows Corbus Pharmaceuticals Holdings, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.66M | $26.98M | $20.04M | $18.90M | $19.42M | $23.69M |
| Short-term investments | $112.56M | $77.00M | $96.55M | $113.89M | $139.94M | $123.34M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $143.57M |
| $107.57M |
| $122.83M |
| $137.36M |
| $160.89M |
| $148.31M |
| Property, plant & equipment | $116.00K | $201.00K | $251.00K | $304.00K | $519.00K | $671.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $144.48M | $109.51M | $125.08M | $139.93M | $164.17M | $151.98M |
| Accounts payable | $435.00K | $2.74M | $3.99M | $4.07M | $2.89M | $1.15M |
| Total current liabilities | $18.14M | $17.06M | $13.33M | $11.62M | $11.63M | $23.98M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $18.14M | $17.37M | $14.09M | $12.82M | $13.67M | $26.44M |
| Retained earnings | -$578.40M | -$534.88M | -$511.53M | -$493.87M | -$467.36M | -$453.58M |
| Total equity | $126.34M | $92.15M | $110.99M | $127.11M | $150.50M | $125.54M |